Chloride, but not unmeasured anions, is correlated with renal bone disease markers

Journal of Nephrology

Volumn 20, Issue 4, 2007, Pages 474-481

  Libório, Alexandra Braga ^a   Noritomi, Danilo Teixeira ^a   de Castro, Manuel Carlos Martins ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acidosis; Chloride; Renal bone disease

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANION; BICARBONATE; CALCIUM; CALCIUM DERIVATIVE; CHLORIDE ION; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D;

ACID BASE BALANCE; ADULT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHLORIDE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERCHLOREMIA; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RENAL OSTEODYSTROPHY;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADULT; ANIONS; BIOLOGICAL MARKERS; CHLORIDES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY;

EID: 36049007079     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998; 13: 2755-60.
2. Horl WH. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant 2004; 19 (Suppl 5): V2-8.
3. Slatopolsky E, Brown A, Dusso A. Pathogenesis of secondary hyperparathyroidism. Kidney Int 1999; 73: S14-9.
4. Kraut JA. Disturbances of acid-base and bone disease in end-stage renal disease. Semin Dial 2000; 13: 261-6.
5. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (Suppl 3): S1-S201.
6. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61: 1444-61.
7. Watson PD. Modeling the effects of proteins on pH in plasma. J Appl Physiol 1999; 86: 1421-7.
8. Fencl V, Rosiing TH. Acid-base disorders in critical care medicine. Annu Rev Med 1989; 40: 17-29.
9. Figge J, Mydosh T, Fencl V. Serum proteins and acid-base equilibria: a follow-up. J Lab Clin Med 1992; 120: 713-9.
10. Kellum JA, Kramer J, Pinsky MR. Strong ion gap: methodology for exploring unexplained anions. J Crit Care 1995; 10: 51-5.
11. Wilkes P. Hypoproteinemia, strong-ion difference, and acid-base status in critical ill patients. J Appl Physiol 1998; 84: 1740-8.
12. Gauthier PM, Szerlip HM. Metabolic acidosis in the intensive care unit. Crit Care Clin 2002; 18: 289-308.
13. Moviat MAM, van Haren FMP, van der Hoeven JG. Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care 2003; 7: R41-5.
14. Rocktaeschel J, Morimatsu H, Uchino S, Goldsmith D, Poustie S, Story D, Gutteridge G, Bellomo R. Acid-base status of critical ill patients with acute renal failure: analysis based on Stewart-Figge methodology. Crit Care 2003; 7: 60-6.
15. Rocktaeschel J, Morimatsu H, Uchino S, Bellomo R. Unmeasured anions in critical ill patients: can they predict mortality? Crit Care Med 2003; 31: 2131-6.
16. Dondorp AM, Chau TT, Phu NH, Mai NT, Loc PP, Chuong LV, Sinh DX, Taylor A, Hien TT, White NJ, Day NP. Unidentified acids of strong prognostic in severe malaria. Crit Care Med 2004; 32: 1683-8.
17. Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med 2004; 32: 1120-4.
18. Bushinsky DA, Chabala JM, Gavrilov KL, Levi-Setti R. Effects of in vivo metabolic acidosis on midcortical bone ion composition. Am J Physiol 1999; 277: F813-9.
19. Frick KK, Bushinsky DA. In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression. Am J Physiol 1999; 277: F750-5.
20. Nordstrom T, Shrode LD, Rotstein OD, Romanek R, Goto T, Heersche JN, Manolson MF, Brisseau GF, Grinstein S. Chronic extracellular acidosis induces plasmalemmal vacuolar type H ATPase activity in osteoclasts. J Biol Chem 1997; 272: 6354-60.
21. Green J, Maor G. Effect of metabolic acidosis on the growth hormone/ IGF-I endocrine axis in skeletal growth centers. Kidney Int 2000; 57: 2258-67.
22. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996; 11: 813-9.
23. Kraut JA. The role of metabolic acidosis in the pathogenesis of renal osteodysthrophy. Adv Ren Replace Ther 1995; 2: 40-51.
24. Coen G, Manni M, Addarl O, Ballanti P, Pasquali M, Chicca S, Mazzaferro S, Napoletano I, Sardella D, Bonucci E. Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. Miner Electrolyte Metab 1995; 21: 375-82.
25. Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship TH. Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 1997; 8: 627-31.
26. Lopez I, Agullera-Tejero E, Estepa JC, Rodriguez M, Felsenfeld AJ. Role of acidosis-induced increases in calcium on PTH secretion in acute metabolic and respiratory acidosis in the dog. Am J Physiol Endocrinol Metab 2004; 286: E780-5.
27. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989; 245: 855-7.
28. al Awqati Q. Chloride channels of intracellular organelles. Curr Opin Cell Biol 1995; 7: 504-8.
29. Schaller S, Henriksen K, Sveigaard C, Heegaard AM, Hélix N, Stahlhut M, Ovejero MC, Johansen JV, Solberg H, Andersen TL, Hougaard D, Berryman M, Shiødt CB, Sorensen BH, Lichtenberg J, Christophersen P, Foged NT, Delaissé JM, Engsig MT, Karsdal MA. The chloride channel inhibitor NS3736 prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 2004; 19: 1144-53.
30. Lemann J Jr, Adams ND, Wilz DR, Brenes LG. Acid and mineral balances and bone in familial proximal renal tubular acidosis. Kidney Int 2000; 58: 1267-77.
31. Oh MS. New perspectives on acid-base balance. Semin Dial 2000; 13: 212-9.
32. Brezina B, Qunibi WY, Nolan CR. Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications. Kidney Int 2004; 66: S39-45.